a public good project by the
Synthesis
Company
of California

Charles Joly Beauparlant | doi.page

0 works0 citations0 h-index

Charles Joly Beauparlant

Centre hospitalier universitaire de Québec(CA)Centre hospitalier de l'Université Laval(CA)

BRCA gene mutations in cancer, Genomics and Chromatin Dynamics, Cancer, Lipids, and Metabolism, Fatty Acid Research and Health, DNA Repair Mechanisms

→ Complexity of the microRNA transcriptome of cow milk and milk-derived extracellular vesicles isolated via differential ultracentrifugation(2019)84 cited
→ Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk(2023)55 cited
→ Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer(2009)46 cited
→ The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer(2019)43 cited
→ The Ovulatory Signal Precipitates LRH-1 Transcriptional Switching Mediated by Differential Chromatin Accessibility(2019)43 cited
→ Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families(2008)38 cited

→ Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families(2007)

30 cited